Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 41% ± 13% | |
oligodendrocyte precursor cell | 14 studies | 68% ± 19% | |
glutamatergic neuron | 12 studies | 51% ± 21% | |
GABAergic neuron | 10 studies | 50% ± 26% | |
neuron | 7 studies | 31% ± 16% | |
interneuron | 6 studies | 57% ± 20% | |
oligodendrocyte | 6 studies | 28% ± 14% | |
amacrine cell | 5 studies | 26% ± 11% | |
endothelial cell | 4 studies | 37% ± 17% | |
glial cell | 4 studies | 37% ± 12% | |
fibroblast | 4 studies | 31% ± 7% | |
Mueller cell | 4 studies | 33% ± 18% | |
GABAergic interneuron | 3 studies | 53% ± 2% | |
granule cell | 3 studies | 40% ± 3% | |
GABAergic amacrine cell | 3 studies | 39% ± 12% | |
glycinergic amacrine cell | 3 studies | 28% ± 11% | |
retinal cone cell | 3 studies | 41% ± 22% | |
Schwann cell | 3 studies | 42% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 41% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1597.47 | 2635 / 2642 | 99% | 29.90 | 701 / 705 |
ovary | 98% | 3223.66 | 177 / 180 | 46% | 3.10 | 198 / 430 |
breast | 91% | 423.01 | 417 / 459 | 40% | 2.83 | 445 / 1118 |
uterus | 85% | 473.01 | 145 / 170 | 33% | 3.43 | 151 / 459 |
intestine | 97% | 785.30 | 937 / 966 | 7% | 0.42 | 37 / 527 |
bladder | 81% | 427.24 | 17 / 21 | 23% | 1.73 | 115 / 504 |
prostate | 82% | 308.53 | 200 / 245 | 20% | 0.87 | 99 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.92 | 1 / 1 |
esophagus | 65% | 302.61 | 941 / 1445 | 30% | 2.73 | 54 / 183 |
adipose | 83% | 418.97 | 994 / 1204 | 0% | 0 | 0 / 0 |
thymus | 68% | 189.47 | 441 / 653 | 14% | 2.10 | 86 / 605 |
heart | 81% | 567.24 | 701 / 861 | 0% | 0 | 0 / 0 |
spleen | 80% | 275.30 | 194 / 241 | 0% | 0 | 0 / 0 |
stomach | 59% | 208.09 | 212 / 359 | 12% | 0.85 | 33 / 286 |
lung | 51% | 175.32 | 292 / 578 | 19% | 1.60 | 222 / 1155 |
blood vessel | 54% | 222.58 | 725 / 1335 | 0% | 0 | 0 / 0 |
skin | 23% | 60.35 | 417 / 1809 | 26% | 4.31 | 123 / 472 |
adrenal gland | 9% | 23.86 | 22 / 258 | 39% | 2.86 | 89 / 230 |
kidney | 16% | 44.15 | 14 / 89 | 29% | 1.44 | 261 / 901 |
liver | 20% | 45.07 | 46 / 226 | 18% | 1.43 | 72 / 406 |
pancreas | 1% | 1.11 | 2 / 328 | 29% | 1.69 | 52 / 178 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.04 | 4 / 45 |
peripheral blood | 4% | 22.58 | 37 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
muscle | 1% | 3.73 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035265 | Biological process | organ growth |
GO_0097104 | Biological process | postsynaptic membrane assembly |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0007612 | Biological process | learning |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0071625 | Biological process | vocalization behavior |
GO_0030182 | Biological process | neuron differentiation |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0051963 | Biological process | regulation of synapse assembly |
GO_0003360 | Biological process | brainstem development |
GO_0099054 | Biological process | presynapse assembly |
GO_0090394 | Biological process | negative regulation of excitatory postsynaptic potential |
GO_0030534 | Biological process | adult behavior |
GO_0021549 | Biological process | cerebellum development |
GO_0035176 | Biological process | social behavior |
GO_0050808 | Biological process | synapse organization |
GO_0007158 | Biological process | neuron cell-cell adhesion |
GO_0097105 | Biological process | presynaptic membrane assembly |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0098793 | Cellular component | presynapse |
GO_0098985 | Cellular component | asymmetric, glutamatergic, excitatory synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030425 | Cellular component | dendrite |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0009986 | Cellular component | cell surface |
GO_0045202 | Cellular component | synapse |
GO_0099634 | Cellular component | postsynaptic specialization membrane |
GO_0060076 | Cellular component | excitatory synapse |
GO_0098983 | Cellular component | symmetric, GABA-ergic, inhibitory synapse |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0031404 | Molecular function | chloride ion binding |
GO_0042043 | Molecular function | neurexin family protein binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NLGN4X |
Protein name | Neuroligin-4, X-linked (Neuroligin X) (HNLX) Neuroligin 4 X-linked |
Synonyms | UNQ365/PRO701 NLGN4 KIAA1260 |
Description | FUNCTION: Cell surface protein involved in cell-cell-interactions via its interactions with neurexin family members. . |
Accessions | ENST00000538097.6 [Q8N0W4-2] ENST00000381092.1 [Q8N0W4-1] ENST00000483337.1 ENST00000381093.6 [Q8N0W4-1] A0A2R8YCI5 Q8N0W4 ENST00000275857.10 [Q8N0W4-1] A0A2R8Y6F7 ENST00000381095.8 [Q8N0W4-1] ENST00000469740.1 |